Article
RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Dezan MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone-Junior A, Sabino EC, Dinardo CL. Blood Cells Mol Dis, 2017. [Citation]
Annotations by Allele
- RHD deletion (RHD*01N.01): Prevalence
- RHD*329C (DVII): AbSpecificity
- RHD*329C (DVII): Prevalence
- RHD*579A,1136T (DAU0.01): Prevalence
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): AbSpecificity
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Prevalence
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): AbSpecificity
- RHD*602G,667G,819A (weak D type 4.0, DAR3.01): Prevalence
- RHD*609A,654C,667G,674T,807G: AbSpecificity
- RHD*609A,654C,667G,674T,807G: Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): Prevalence
- standard RHD (RHD*01): AbSpecificity
- standard RHD (RHD*01): Prevalence